Association of plasma growth arrest-specific protein 6 (Gas6) concentrations with albuminuria in patients with type 2 diabetes

References

• International Diabetes Federation Diabetes Atlas, 5th ed. Available at: http://www.idf.org/diabetesatlas/5e/Update2012. Accessed May 2013
   Google Scholar
• KDOQI: KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis. 2007;49(2 Suppl 2):12–154
   Google Scholar
• Kanwar YS, Wada J, Sun L, et al. Diabetic nephropathy: mechanisms of renal disease progression. Exp Biol Med. 2008;233:4–11
   PubMed Web of Science ®Google Scholar
• Yanagita M. The role of the vitamin K dependent growth factor Gas6 in glomerular pathophysiology. Curr Opin Nephrol Hypertens. 2004;13:465–470
   PubMedGoogle Scholar
• Nagai K, Arai H, Yanagita M, et al. Growth arrest-specific gene 6 is involved in glomerular hypertrophy in the early stage of diabetic nephropathy. J Biol Chem. 2003;278:18229–18234
   PubMed Web of Science ®Google Scholar
• Mima A, Arai H, Matsubara T, et al. Urinary Smad1 is a novel marker to predict later onset of mesangial matrix expansion in diabetic nephropathy. Diabetes. 2008;57:1712–1722
   PubMedGoogle Scholar
• Johnson RJ, Floege J, Couser WG, Alpers CE. Role of platelet derived growth factor in glomerular disease. J Am Soc Nephrol. 1993;4:119–128
   PubMed Web of Science ®Google Scholar
• Floege J, Eng E, Lindner V, et al. Rat glomerular mesangial cells synthesize basic fibroblast growth factor. Release, upregulated synthesis, and mitogenicity in mesangial proliferative glomerulonephritis. J Clin Invest. 1992;90:362–369
   Google Scholar
• Ryffel B, Car BD, Gunn H, Roman D, Hiestand P, Mihatsch MJ. Interleukin-6 exacerbates glomerulonephritis in (NZBxNZW)F1 mice. Am J Pathol. 1994;144:927–937
   PubMed Web of Science ®Google Scholar
• Goruppi S, Ruaro E, Schneider C. Gas6, the ligand of Axl tyrosine kinase receptor, has mitogenic and survival activities for serum starved NIH3T3 fibroblasts. Oncogene. 1996;12:471–480
   PubMed Web of Science ®Google Scholar
• McCloskey P, Fridell YW, Attar E, et al. Gas6 mediates adhesion of cells expressing the receptor tyrosine kinase Axl. J Biol Chem. 1997;272:23285–23291
   PubMed Web of Science ®Google Scholar
• Fridell YW, Villa J Jr, Attar EC, Liu ET. Gas6 induces Axl-mediated chemotaxis of vascular smooth muscle cells. J Biol Chem. 1998;273:7123–7126
   PubMed Web of Science ®Google Scholar
• Schneider C, King RM, Philipson L. Genes specifically expressed at growth arrest of mammalian cells. Cell. 1998;54:787–793
   Google Scholar
• Manfioletti G, Brancolini C, Avanzi G, Schneider C. The protein encoded by a growth arrest-specific gene (Gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade. Mol Cell Biol. 1993;13:4976–4985
   PubMed Web of Science ®Google Scholar
• Esmon CT, Sadowski JA, Suttie JW. A new carboxylation reaction. The vitamin K-dependent incorporation of H14CO3− into prothrombin. J Biol Chem. 1975;250:4744–4748
   PubMed Web of Science ®Google Scholar
• Tetik S, Uras F, Eksioglu-Demiralp E, Turay Yardimci K. Low-density lipoprotein specifically binds glycoprotein IIb/IIIa. A flow cytometric method for ligand-receptor interaction. Clin Appl Thromb Hemost. 2008;14:210–219
   PubMedGoogle Scholar
• Ozsavci D, Yardimci T, Demirel GY, Demiralp E, Uras F, Onder E. Flow cytometric assay of platelet glycoprotein receptor numbers in hypercholesterolemia. Platelets. 2002;13:223–229
   PubMed Web of Science ®Google Scholar
• Ozsavci D, Yardimci T, Demirel GY, Uras F, Hekim N, Ulutin ON. Apo-A1 binding to platelets detected by flow cytometry. Thromb Res. 2001;103:117–122
   PubMedGoogle Scholar
• Uras F, Uras AR, Yardımcı T, Sardana MK. Determination of the N-terminal amino acid sequence of the purified prothrombin from a patient with liver cirrhosis. Thromb Res. 2000;99:277–283
   PubMed Web of Science ®Google Scholar
• Koldas M, Uras F. Avidin-biotin ELISA for measurement of prothrombin in human plasma. Thromb Res. 2001;102:221–227
   PubMed Web of Science ®Google Scholar
• Avanzi GC, Callicchio M, Bottarel F, et al. Gas 6 inhibits granulocyte adhesion to endothelial cells. Blood. 1998;91:2334–2340
   PubMed Web of Science ®Google Scholar
• Nakano T, Higashino K, Kikuchi N, et al. Vascular smooth muscle cell-derived, Gla-containing growth potentiating factor for Ca (2+)-mobilizing growth factors. J Biol Chem. 1995;270:5702–5705
   PubMed Web of Science ®Google Scholar
• Fiebeler A, Park JK, Muller DN, et al. Growth arrest specific protein 6/Axl signaling in human inflammatory renal diseases. Am J Kidney Dis. 2004;43:286–295
   PubMed Web of Science ®Google Scholar
• Arai H, Nagai K, Doi T. Role of growth arrest-specific gene 6 in diabetic nephropathy. Vitam Horm. 2008;78:375–392
   PubMed Web of Science ®Google Scholar
• Nagai K, Matsubara T, Mima A, et al. Gas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathy. Kidney Int. 2005;68:552–561
   PubMed Web of Science ®Google Scholar
• Yanagita M, Ishii K, Ozaki H, et al. Mechanism of inhibitory effect of warfarin on mesangial cell proliferation. J Am Soc Nephrol. 1999;10:2503–2509
   PubMed Web of Science ®Google Scholar
• Suzuki LA, Poot M, Gerrity RG, Bornfeldt KE. Diabetes accelerates smooth muscle accumulation in lesions of atherosclerosis: lack of direct growth-promoting effects of high glucose levels. Diabetes. 2001;50:851–860
   PubMed Web of Science ®Google Scholar
• Yin, JL, Pilmore HL, Yan YQ, et al. Expression of growth arrest-specific gene 6 and its receptors in a rat model of chronic renal transplant rejection. Transplantation. 2002;73:657–660
   PubMedGoogle Scholar
• Hung YJ, Lee CH, Chu NF, Shieh YS. Plasma protein growth arrest-specific 6 levels are associated with altered glucose tolerance, inflammation, and endothelial dysfunction. Diabetes Care. 2010;33:1840–1844
   PubMed Web of Science ®Google Scholar
• Chavers BM, Bilous RW, Ellis EN, Steffes MW, Mauer SM. Glomerular lesions and urinary albumin excretion in type I diabetes without overt proteinuria. N Engl J Med. 1989;320:966–970
   PubMed Web of Science ®Google Scholar
• Fioretto P, Steffes MW, Mauer M. Glomerular structure in nonproteinuric IDDM patients with various levels of albuminuria. Diabetes. 1994;43:1358–1364
   PubMed Web of Science ®Google Scholar
• Dihazi H, Müller GA, Lindner S, et al. Characterization of diabetic nephropathy by urinary proteomic analysis: identification of a processed ubiquitin form as a differentially excreted protein in diabetic nephropathy patients. Clin Chem. 2007;53:1636–1645
   PubMed Web of Science ®Google Scholar
• Lengyel Z, Voros P, Toth LK, et al. Urinary albumin excretion is correlated to fibrinogen levels and protein S activity in patients with type 1 diabetes mellitus without overt diabetic nephropathy. Wien Klin Wochenschr. 2004;116:240–245
   PubMedGoogle Scholar
• Tessari P, Kiwanuka E, Barazzoni R, Vettore M, Zanetti M. Diabetic nephropathy is associated with increased albumin and fibrinogen production in patients with type 2 diabetes. Diabetologia. 2006;49:1955–1961
   PubMedGoogle Scholar
• Takebayashi K, Suetsugu M, Matsutomo R, Wakabayashi S, Aso Y, Inukai T. Correlation of high-sensitivity C-reactive protein and plasma fibrinogen with individual complications in patients with type 2 diabetes. South Med J. 2006;99:23–27
   PubMedGoogle Scholar
• Navarro-Gonzalez JF, Mora-Fernandez C, de Fuentes MM, Garcia-Perez J. Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nat Rev Nephrol. 2011; 7: 327–340
   PubMed Web of Science ®Google Scholar
• Lu J, Randell E, Han Y, Adeli K, Krahn J, Meng QH. Increased plasma methylglyoxal level, inflammation, and vascular endothelial dysfunction in diabetic nephropathy. Clin Biochem. 2011;44:307–311
   PubMed Web of Science ®Google Scholar
• Cavet ME, Smolock EM, Ozturk OH, et al. Gas6-axl receptor signaling is regulated by glucose in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2008;28:886–891
   PubMedGoogle Scholar
• Augustine KA, Rossi R, Van G, et al. Noninsulin-dependent diabetes mellitus occurs in mice ectopically expressing the human Axl tyrosine kinase receptor. J Cell Physiol. 1999;181:433–447
   PubMedGoogle Scholar